Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TNFRSF1A | P19438 | 2/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.38 |
| ▸ | FEN1 | P39748 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30921753 | 0.97 | CA2 (0.48) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL6677826 | 0.91 | CA2 (0.43) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL8417921 | 0.86 | SMN1; SMN2 (0.47) | CA2ALDH1A1KDM4EMAPK1SMN1; SMN2 | |
| SCHEMBL11646260 | 0.86 | GABRA1 (0.52) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL31438691 | 0.86 | SMN1; SMN2 (0.47) | CA2ALDH1A1KDM4EMAPK1SMN1; SMN2 | |
| SCHEMBL16957908 | 0.84 | CA2 (0.41) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL29488075 | 0.84 | ALDH1A1 (0.56) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL5090616 | 0.84 | CA2 (0.41) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL13310501 | 0.84 | CA2 (0.41) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL6041965 | 0.84 | CA2 (0.41) | CA2GABRA1GABRB2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119118853-A | Polyurethane curing agent and application thereof in preparation of elastomer | 东莞市优骏橡塑制品有限公司 | 2024-12-13 | — | — | CN | claimed |
| EP-3122819-B1 | MELT POLYMERIZATION POLYCARBONATE QUENCHING TECHNICAL FIELD | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-07-19 | — | — | EP | claimed |
| US-10766833-B2 | Hydroformylation method and catalyst using rhodium-ruthenium dual metal and tetradentate phosphine ligand | Wuhan Catalys Technology CO., LTD (CN) | 2020-09-08 | — | — | US | claimed |
| EP-3568418-A2 | BRIDGED BIS(INDENYL) TRANSITIONAL METAL COMPLEXES, PRODUCTION, AND USE THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2019-11-20 | — | — | EP | claimed |
| US-20190337866-A1 | HYDROFORMYLATION METHOD AND CATALYST USING RHODIUM-RUTHENIUM DUAL METAL AND TETRADENTATE PHOSPHINE LIGAND | Wuhan Catalys Technology CO., LTD (CN) | 2019-11-07 | — | — | US | claimed |
| WO-2018132247-A2 | BRIDGED BIS(INDENYL) TRANSITIONAL METAL COMPLEXES, PRODUCTION, AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-07-19 | — | — | WO | claimed |
| US-20180201630-A1 | Bridged Bis(Indenyl) Transitional Metal Complexes, Production, and Use Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-07-19 | — | — | US | claimed |
| US-9803049-B2 | Melt polymerization polycarbonate quenching | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-10-31 | — | — | US | claimed |
| CN-106824282-A | The hydroformylation reaction method and catalyst of a kind of use rhodium ruthenium bimetallic and four tooth Phosphine ligands | 武汉凯特立斯科技有限公司 | 2017-06-13 | — | — | CN | claimed |
| CN-106622376-A | Internal olefin isomerization and hydroformylation reaction method, and catalyst | 武汉凯特立斯科技有限公司 | 2017-05-10 | — | — | CN | claimed |
| CN-103804413-B | Three Phosphine ligands preparation method of biphenyl and progressively replace PPh in hydroformylation3Application | 武汉大学 | 2017-03-15 | — | — | CN | claimed |
| EP-3122819-A1 | MELT POLYMERIZATION POLYCARBONATE QUENCHING | SABIC Global Technologies B.V. (NL) | 2017-02-01 | — | — | EP | claimed |
| US-20170002139-A1 | MELT POLYMERIZATION POLYCARBONATE QUENCHING | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-01-05 | — | — | US | claimed |
| WO-2015145381-A1 | MELT POLYMERIZATION POLYCARBONATE QUENCHING | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-10-01 | — | — | WO | claimed |
| EP-2490291-B1 | LITHIUM SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTIC SOLUTION FOR USE IN THE LITHIUM SECONDARY BATTERY | UBE INDUSTRIES (JP) | 2014-12-03 | — | — | EP | claimed |
| CN-103594750-A | Floating charge resistant lithium ion battery module and floating charge method thereof | SHANGHAI AEROSPACE POWER TECHNOLOGY CO LTD | 2014-02-19 | — | — | CN | claimed |
| EP-2490291-A1 | LITHIUM SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTIC SOLUTION FOR USE IN THE LITHIUM SECONDARY BATTERY | Ube Industries, Ltd. (JP) | 2012-08-22 | — | — | EP | claimed |
| US-20120183846-A1 | LITHIUM SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTIC SOLUTION FOR USE IN THE LITHIUM SECONDARY BATTERY | UBE INDUSTRIES, LTD. (JP) | 2012-07-19 | — | — | US | claimed |
| CN-116234794-B | Low reactivity hydrocarbon dispersants in aqueous polymerization of fluoropolymers | THE CHEMOURS COMPANY FC, LLC (US) | 2026-05-26 | — | — | CN | disclosed |
| US-4101326-A | Process for making stabilized polyesters used in radiation-sensitive compositions for lithographic plates having improved wear life including hindered phenols and phosphoric acid esters | EASTMAN KODAK COMPANY (US) | 1978-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180201630-A1 | Bridged Bis(Indenyl) Transitional Metal Complexes, Production, and Use Thereof | PCBP1, PARG, PARN | CA2 3024/4885GABRA1 3293/4885GABRB2 3321/4885 |
| US-20190337866-A1 | HYDROFORMYLATION METHOD AND CATALYST USING RHODIUM-RUTHENIUM DUAL METAL AND TETRADENTATE PHOSPHINE LIGAND | HRH4, PPIP5K2, NUDT1 | CA2 1079/4885GABRA1 4193/4885GABRB2 4090/4885 |
| US-10766833-B2 | Hydroformylation method and catalyst using rhodium-ruthenium dual metal and tetradentate phosphine ligand | HRH4, PPIP5K2, NUDT1 | CA2 1079/4885GABRA1 4193/4885GABRB2 4090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.